Active ingredients: indacaterol + glycopyrronium
What it is used for
ULTIBRO BREEZHALER 110/50 is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (COPD), and for the reduction of exacerbations of COPD in patients with a history of exacerbations.
How to take it
The way to take this medicine is: Inhalation.
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Capsule: Transparent yellow cap and natural transparent body with black Novartis logo on cap and blue IGP110.50 under two blue bars on body
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient indacaterol + glycopyrronium
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems